Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

LRRK2 kinase inhibition prevents pathological microglial phagocytosis in response to HIV-1 Tat protein
Daniel F. Marker, Jenna M. Puccini, Taryn E. Mockus, et al.
Journal of Neuroinflammation (2012) Vol. 9, Iss. 1
Open Access | Times Cited: 90

Showing 26-50 of 90 citing articles:

Swimming short fibrous nasal drops achieving intraventricular administration
Juan Wang, Qiuyun Wang, Yifei Fu, et al.
Science Bulletin (2024) Vol. 69, Iss. 9, pp. 1249-1262
Closed Access | Times Cited: 12
Immune Responses in Parkinson’s Disease: Interplay between Central and Peripheral Immune Systems
Xiaomin Su, Howard J. Federoff
BioMed Research International (2014) Vol. 2014, pp. 1-9
Open Access | Times Cited: 86
Discovery, Synthesis, and Characterization of an Orally Bioavailable, Brain Penetrant Inhibitor of Mixed Lineage Kinase 3
Val S. Goodfellow, Colin J. Loweth, R. Satheesh Babu, et al.
Journal of Medicinal Chemistry (2013) Vol. 56, Iss. 20, pp. 8032-8048
Open Access | Times Cited: 80
LRRK2 Kinase Activity Induces Mitochondrial Fission in Microglia via Drp1 and Modulates Neuroinflammation
Dong Hwan Ho, A Reum Je, Hae-Jin Lee, et al.
Experimental Neurobiology (2018) Vol. 27, Iss. 3, pp. 171-180
Open Access | Times Cited: 80
The G2019S LRRK2 mutation increases myeloid cell chemotactic responses and enhances LRRK2 binding to actin-regulatory proteins
Mark S. Moehle, João Paulo Lima Daher, Travis D. Hull, et al.
Human Molecular Genetics (2015) Vol. 24, Iss. 15, pp. 4250-4267
Open Access | Times Cited: 72
LRRK2 mediates microglial neurotoxicity via NFATc2 in rodent models of synucleinopathies
Changyoun Kim, A Beilina, Nathan Smith, et al.
Science Translational Medicine (2020) Vol. 12, Iss. 565
Open Access | Times Cited: 64
Transcriptome analysis of LRRK2 knock-out microglia cells reveals alterations of inflammatory- and oxidative stress-related pathways upon treatment with α-synuclein fibrils
Isabella Russo, Alice Kaganovich, Jinhui Ding, et al.
Neurobiology of Disease (2019) Vol. 129, pp. 67-78
Open Access | Times Cited: 63
Effect of LRRK2 protein and activity on stimulated cytokines in human monocytes and macrophages
Diba Ahmadi Rastegar, Laura P. Hughes, Gayathri Perera, et al.
npj Parkinson s Disease (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 30
The involvement of α-synucleinopathy in the disruption of microglial homeostasis contributes to the pathogenesis of Parkinson’s disease
Yongzhen Miao, Hongrui Meng
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 7
LRRK2 kinase inhibition protects against Parkinson's disease-associated environmental toxicants
Neda M. Ilieva, Eric K. Hoffman, Mohammed Ghalib, et al.
Neurobiology of Disease (2024) Vol. 196, pp. 106522-106522
Open Access | Times Cited: 7
The New Small-Molecule Mixed-Lineage Kinase 3 Inhibitor URMC-099 Is Neuroprotective and Anti-Inflammatory in Models of Human Immunodeficiency Virus-Associated Neurocognitive Disorders
Daniel F. Marker, Marie‐Ève Tremblay, Jenna M. Puccini, et al.
Journal of Neuroscience (2013) Vol. 33, Iss. 24, pp. 9998-10010
Open Access | Times Cited: 64
Phosphoproteomic evaluation of pharmacological inhibition of leucine‐rich repeat kinase 2 reveals significant off‐target effects of LRRK‐2‐IN‐1
Gregory C. Luerman, Chuong Nguyen, Harry Samaroo, et al.
Journal of Neurochemistry (2013) Vol. 128, Iss. 4, pp. 561-576
Open Access | Times Cited: 63
Role of LRRK2 in manganese-induced neuroinflammation and microglial autophagy
Jiayan Chen, Peng Su, Wenjing Luo, et al.
Biochemical and Biophysical Research Communications (2018) Vol. 498, Iss. 1, pp. 171-177
Closed Access | Times Cited: 57
The cross-talk of HIV-1 Tat and methamphetamine in HIV-associated neurocognitive disorders
Sonia Mediouni, Maria Cecília Garibaldi Marcondes, Courtney A. Miller, et al.
Frontiers in Microbiology (2015) Vol. 6
Open Access | Times Cited: 56
Leucine-Rich Repeat Kinase 2 Modulates Neuroinflammation and Neurotoxicity in Models of Human Immunodeficiency Virus 1-Associated Neurocognitive Disorders
Jenna M. Puccini, Daniel F. Marker, Tim Fitzgerald, et al.
Journal of Neuroscience (2015) Vol. 35, Iss. 13, pp. 5271-5283
Open Access | Times Cited: 53
LRRK2 and the Immune System
Nicolas Dzamko
Advances in neurobiology (2017), pp. 123-143
Closed Access | Times Cited: 49
LRRK2 as a target for modulating immune system responses
Isabella Russo, Luigi Bubacco, Elisa Greggio
Neurobiology of Disease (2022) Vol. 169, pp. 105724-105724
Open Access | Times Cited: 24
Involvement of the Rabies Virus Phosphoprotein Gene in Neuroinvasiveness
Satoko Yamaoka, Naoto Ito, Seii Ohka, et al.
Journal of Virology (2013) Vol. 87, Iss. 22, pp. 12327-12338
Open Access | Times Cited: 51
Leucine-rich repeat kinase-2 (LRRK2) modulates microglial phenotype and dopaminergic neurodegeneration
Zach Dwyer, Chris Rudyk, Ashley Thompson, et al.
Neurobiology of Aging (2020) Vol. 91, pp. 45-55
Open Access | Times Cited: 38
Basic Concept of Microglia Biology and Neuroinflammation in Relation to Psychiatry
Daniele Mattei, Tina Notter
Current topics in behavioral neurosciences (2019), pp. 9-34
Open Access | Times Cited: 37
Integrated network analysis reveals new genes suggesting COVID-19 chronic effects and treatment
Alisa Pavel, Giusy del Giudice, Antonio Federico, et al.
Briefings in Bioinformatics (2020) Vol. 22, Iss. 2, pp. 1430-1441
Open Access | Times Cited: 36
Cross-talk between LRRK2 and PKA: implication for Parkinson's disease?
Elisa Greggio, Luigi Bubacco, Isabella Russo
Biochemical Society Transactions (2017) Vol. 45, Iss. 1, pp. 261-267
Open Access | Times Cited: 34
The role of posttranslational modifications of α-synuclein and LRRK2 in Parkinson's disease: Potential contributions of environmental factors
Edward Pajarillo, Asha Rizor, Jayden Lee, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2018) Vol. 1865, Iss. 8, pp. 1992-2000
Open Access | Times Cited: 33
The broad spectrum mixed-lineage kinase 3 inhibitor URMC-099 prevents acute microgliosis and cognitive decline in a mouse model of perioperative neurocognitive disorders
Patrick Miller‐Rhodes, Cuicui Kong, Gurpreet S. Baht, et al.
Journal of Neuroinflammation (2019) Vol. 16, Iss. 1
Open Access | Times Cited: 30
miR-335 Targets LRRK2 and Mitigates Inflammation in Parkinson’s Disease
Sara R. Oliveira, Pedro A. Dionísio, Maria Manuela Gaspar, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 26

Scroll to top